================================================================================
SEC 1745 POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
(6-01) CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM
DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.
================================================================================
-------------------------------
OMB APPROVAL
OMB Number: 3235-0145
Expires: October 31, 2002
Estimated average burden
hours per response. . . 14.9
-------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
Interleuken Genetics, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
458738101
--------------------------------------------------------------------------------
(CUSIP Number)
August, 2001
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent
amendment containing information which would alter the disclosures provided in a
prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 458738101
-------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
a) Stephen Garofalo
b) First Global Technology Corp. Fed ID # 11-3402873
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) .....................................................................
(b) .....................................................................
--------------------------------------------------------------------------------
3. SEC Use Only...............................................................
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization
a) United States
b) Federal Global Technology Corp. incorporated in New York.
--------------------------------------------------------------------------------
5. Sole Voting Power
0
Number of --------------------------------------------------------------
Shares 6. Shared Voting Power
Beneficially 1,535,967
Owned by --------------------------------------------------------------
Each Reporting 7. Sole Dispositive Power
Person With 0
--------------------------------------------------------------
8. Shared Dispositive Power
1,535,967
--------------------------------------------------------------------------------
Aggregate Amount Beneficially Owned by Each Reporting Person
9. a) Stephen Garofalo - 720,000 shares
b) First Global Technology Corp. - 815,967 shares
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)........................................
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
a) Stephen Garofalo -3.36%
b) First Global Technology Corp. -3.81%
--------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
--------------------------------------------------------------------------------
a) Stephen Garofalo - IN
................................................................................
b) First Global Technology Corp. - CO
................................................................................
................................................................................
................................................................................
................................................................................
................................................................................
--------------------------------------------------------------------------------
Item 1.
(a) Name of Issuer
Interleukin Genetics, Inc.
(b) Address of Issuer's Principal Executive Offices
135 Beaver Street, Waltham, Massachusetts 02452
Item 2.
(a) Name of Person Filing
(i) Stephen Garofalo
(ii) First Global Technology Corp.
(b) Address of Principal Business Office or, if none, Residence:
(i) 6 Teal Court, New City, New York 10956-3156
(ii) 6 Teal Court, New City, New York 10956-3156
(c) Citizenship
(i) United States
(ii) Incorporated in New York
(d) Title of Class of Securities
Common stock, no par value
(e) CUSIP Number
458738101
ITEM 3. If this statement is filed pursuant to (Sections) 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o).
(b) [ ] Bank as defined in section 3(a)(6) of the Act
(15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with
(Section)240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance
with (Section)240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance
with (Section)240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] Group, in accordance with (Section)240.13d-1(b)(1)(ii)(J).
ITEM 4. Ownership.
Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 1,535,967.
(b) Percent of class: 7.17.
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 0.
(ii) Shared power to vote or to direct the vote: 1,535,967.
(iii) Sole power to dispose or to direct the disposition of : 0.
(iv) Shared power to dispose or to direct the disposition of : 1,535,967.
Instruction. For computations regarding securities which represent a right to
acquire an underlying security see (Section)240.13d3(d)(1).
ITEM 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the
following [ ].
Instruction: Dissolution of a group requires a response to this item.
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. - N/A
If any other person is known to have the right to receive or the power to direct
the receipt of dividends from, or the proceeds from the sale of, such
securities, a statement to that effect should be included in response to this
item and, if such interest relates to more than five percent of the class, such
person should be identified. A listing of the shareholders of an investment
company registered under the Investment Company Act of 1940 or the beneficiaries
of employee benefit plan, pension fund or endowment fund is not required.
ITEM 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company - N/A
If a parent holding company has filed this schedule, pursuant to Rule
13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the
identity and the Item 3 classification of the relevant subsidiary. If a parent
holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule
13d-1(d), attach an exhibit stating the identification of the relevant
subsidiary.
ITEM 8. Identification and Classification of Members of the Group - N/A
If a group has filed this schedule pursuant to (Section)240.13d-1(b)(1)(ii)(J),
so indicate under Item 3(j) and attach an exhibit stating the identity and Item
3 classification of each member of the group. If a group has filed this schedule
pursuant to (Section)240.13d-1(c) or (Section)240.13d-1(d), attach an exhibit
stating the identity of each member of the group.
The members of the Group are: Stephen Garofalo and First Global Technology Corp.
Stephen Garofalo owns 100% of First Global Technology Corp.
ITEM 9. Notice of Dissolution of Group - N/A
Notice of dissolution of a group may be furnished as an exhibit stating the date
of the dissolution and that all further filings with respect to transactions in
the security reported on will be filed, if required, by members of the group, in
their individual capacity. See Item 5.
ITEM 10. Certification
(a) The following certification shall be included if the statement is
filed pursuant to
(Section)240.13d-1(b):
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
(b) The following certification shall be included if the statement is
filed pursuant to (Section)240.13d-1(c):
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
August 8, 2001
---------------------------------
Date
/s/ Stephen Garofalo
---------------------------------
Signature
Stephen Garofalo
----------------
Name/Title
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
August 8, 2001
---------------------------------
Date
/s/ Stephen Garofalo
---------------------------------
Signature
Stephen Garofalo/Sole Shareholder, Officer
------------------------------------------
and Director of First Global Technology Corp.
---------------------------------------------
Name/Title